Foxo technologies™ interim ceo mark white provides letter to shareholders outlining new ai-enabled direct-to-consumer strategy and immediate expense reductions

Minneapolis--(business wire)--foxo technologies inc. (nyse american: foxo) (“foxo” or the “company”), a leader in the field of commercializing epigenetic biomarker technology, today provided a letter to shareholders from the company's newly appointed interim ceo, mark white. “while this has been a turbulent period for the company, i am honored to take the helm of foxo technologies. before accepting this role, i undertook a comprehensive review of the technology and market potential for foxo's p.
FOXO Ratings Summary
FOXO Quant Ranking